Lightning Talk: Overcoming Bottlenecks in Drug Development: The Future of Nanoparticle Characterization

The rapid advancement of mRNA therapies, gene editing, and personalised medicine is transforming drug development, yet analytical bottlenecks in nanoparticle characterisation slow down progress. This session explores how emerging technologies, AI-driven data processing, and innovative analytical methodologies can enhance nanoparticle quality control, improve reproducibility, and accelerate regulatory approvals. Drawing from real-world case studies and industry trends, we will discuss the future of bio-manufacturing and how to make next-generation therapies more accessible, scalable, and cost-effective.